1. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016; 388(10063):3027–3035.
2. You D, Hug L, Ejdemyr S, et al. Global, regional, and national levels and trends in under-5 mortality between 1990 and 2015, with scenario-based projections to 2030: A systematic analysis by the un Inter-Agency Group for Child Mortality Estimation. Lancet. 2015; 386(10010):2275–2286.
3. Troeger C, Forouzanfar M, Rao PC, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017; 17(11):1133–1161.
4. Troeger C, Blacker B, Khalil IA, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018; 18(11):1191–1210.
5. The Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019; 6736(19):1–23.
6. Zar HJ, Barnett W, Stadler A, Gardner-Lubbe S, Myer L, Nicol MP. Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: A nested case-control study of the Drakenstein Child Health Study. Lancet Respir Med. 2016; 4(6):463–472.
7. Nguyen TKP, Tran TH, Roberts CL, Graham SM, Marais BJ. Child pneumonia – focus on the Western Pacific Region. Paediatr Respir Rev. 2017; 21:102–110.
8. World Health Organization. Revised WHO classification and treatment of pneumonia in children at health facilities: evidence summaries. 2014. Available at: https://www.who.int/maternal_child_adolescent/documents/child-pneumonia-treatment/en/. Accessed on 12 Sep, 2019.
9. Shi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017; 390(10098):946–958.
10. Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: A systematic review and meta-analysis. Lancet. 2011; 378(9807):1917–1930.
11. Roux DM le, Nicol MP, Myer L, et al. Lower Respiratory Tract Infections in Children in a Well- vaccinated South African Birth Cohort: Spectrum of Disease and Risk Factors. Clin Infect Dis. 2019; In press.
12. Roux DM Le, Myer L, Nicol MP, Zar HJ. Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: The Drakenstein Child Health Study. Lancet Glob Heal. 2015; 3(2):e95–e103.
13. Nokes DJ, Okiro EA, Ngama M, et al. Respiratory Syncytial Virus Epidemiology in a Birth Cohort from Kilifi District, Kenya: Infection during the First Year of Life. J Infect Dis. 2004; 190(10):1828– 1832.
14. Broor S, Parveen S, Bharaj P, et al. A Prospective Three-Year Cohort Study of the Epidemiology and Virology of Acute Respiratory Infections of Children in Rural India. PLoS One. 2007; 2(6):e491.
15. Nokes DJ, Okiro EA, Ngama M, et al. Respiratory Syncytial Virus Infection and Disease in Infants and Young Children Studied from Birth in Kilifi District , Kenya. Clin Infect Dis. 2008; 46(1):50–57.
16. Kubale J, Kuan G, Gresh L, et al. Assessing the Incidence of Symptomatic Respiratory Syncytial Virus Illness Within a Prospective Birth Cohort in Managua, Nicaragua. Clin Infect Dis [Internet]. 2019; (In press).
17. Gresh L, Kuan G, Sanchez N, et al. Burden of Influenza and Influenza-associated Pneumonia in the First Year of Life in a Prospective Cohort Study in Managua, Nicaragua. Pediatr Infect Dis J. 2016; 35(2):152–156.
18. Ison MG, Hayden RT. Adenovirus. Microbiol Spectrum. 2015; 4(4).
19. Royston L, Tapparel C. Rhinoviruses and respiratory enteroviruses: Not as simple as ABC. Viruses. 2016; 8(1).
20. Holm-Hansen CC, Midgley SE, Fischer TK. Global emergence of enterovirus D68: A systematic review. Lancet Infect Dis. 2016; 16(5):e64–e75.
21. Griffiths C, Drews SJ, Marchant DJ. Respiratory syncytial virus: Infection, detection, and new options for prevention and treatment. Clin Microbiol Rev. 2017; 30(1):277–319.
22. Mazur NI, Higgins D, Nunes MC, et al. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. Lancet Infect Dis. 2018; 18(10):e295–e311.
23. 日本小児科学会 予防接種・感染症対策委員会, 「日本におけるパリビズマブの使用に関するガイドライン」改訂検討ワーキンググループ. 日本におけるパリビズマブの使用に関するコンセンサスガイドライン. 日本小児科学会雑誌. 2019. Available at: http://www.jpeds.or.jp/uploads/files/20190402palivizumabGL.pdf. Accessed on 15 Sep, 2019.
24. Schildgen V, Hoogen B van den, Fouchier R, et al. Human metapneumovirus: Lessons learned over the first decade. Clin Microbiol Rev. 2011; 24(4):734–754.
25. Karron RA, Collins PL. Parainfluenza viruses. Fields Virol Sixth Ed. 2013; 1(2):242–264.
26. World Health Organization. Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec. 2012; 47(87):461–476.
27. Su S, Wong G, Shi W, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016; 24(6):490–502.
28. Peltola V, Söderlund-Venermo M, Jartti T. Human bocavirus infections. Pediatr Infect Dis J. 2013; 32(2):178–179.
29. Iaria M, Caccuri F, Apostoli P, et al. Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients. Clin Microbiol Infect. 2015; 21(6):603.e9-603.e15.
30. Esposito S, Rahamat-Langendoen J, Ascolese B, Senatore L, Castellazzi L, Niesters HGM. Pediatric parechovirus infections. J Clin Virol. 2014; 60(2):84–89.
31. Sarna M, Lambert SB, Sloots TP, et al. Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort. Thorax. 2017; thoraxjnl-2017-210233.
32. Sarna M, Ware RS, Lambert SB, Sloots TP, Nissen MD, Grimwood K. Timing of First Respiratory Virus Detections in Infants: A Community-Based Birth Cohort Study. J Infect Dis. 2018; 217(3):418–427.
33. Kusel MMH, Klerk NH de, Holt PG, Kebadze T, Johnston SL, Sly PD. Role of Respiratory Viruses in Acute Upper and Lower Respiratory Tract Illness in the First Year of Life. Pediatr Infect Dis J. 2006; 25(8):680–686.
34. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus. Am J Dis Child. 1986; 140(6):543–546.
35. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in children. Semin Pediatr Infect Dis. 1997; 16(11):1065–1068.
36. Marchant A, Sadarangani M, Garand M, et al. Maternal immunisation: collaborating with mother nature. Lancet Infect Dis. 2017; 17(7):e197–e208.
37. Zomer-Kooijker K, Ent CK Van Der, Ermers MJJ, Uiterwaal CSPM, Rovers MM, Bont LJ. Increased risk of wheeze and decreased lung function after respiratory syncytial virus infection. PLoS One. 2014; 9(1): e87162.
38. Szabo SM, Gooch KL, Korol EE, et al. A population-based study of childhood respiratory morbidity after severe lower respiratory tract infections in early childhood. J Pediatr. 2014; 165(1):123- 128.e3.
39. Fjærli HO, Farstad T, Rød G, Ufert GK, Gulbrandsen P, Nakstad B. Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway. BMC Pediatr. 2005; 5:1–8.
40. Henderson J, Hilliard TN, Sherriff A, Stalker D, Shammari N Al, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study. Pediatr Allergy Immunol. 2005; 16(5):386–392.
41. Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010; 65(12):1045–1052.
42. Bønnelykke K, Vissing NH, Sevelsted A, Johnston SL, Bisgaard H. Association between respiratory infections in early life and later asthma is independent of virus type. J Allergy Clin Immunol . 2015; 136(1):81-86.e4.
43. Backman K, Ollikainen H, Piippo-Savolainen E, Nuolivirta K, Korppi M. Asthma and lung function in adulthood after a viral wheezing episode in early childhood. Clin Exp Allergy. 2018; 48(2):138– 146.
44. Stein RT, Sherrill D, Morgan WJ, et al. RSV Infection and Increased Wheezing. Lancet. 1999; .
45. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008; 178(7):667–672.
46. Homaira N, Briggs N, Oei J-L, et al. Association of Age at First Severe Respiratory Syncytial Virus Disease With Subsequent Risk of Severe Asthma: A Population-Based Cohort Study. J Infect Dis. 2018; 220(4):550–556.
47. Toizumi M, Suzuki M, Nguyen HAT, et al. Viral Acute Respiratory Illnesses in Young Infants Increase the Risk of Respiratory Readmission. Pediatr Infect Dis J. 2018; 37(12):1217–1222.
48. Simões EAF, Chirikov V, Botteman M, Kwon Y, Kuznik A. Long-Term Assessment of Healthcare Utilization Five Years After Respiratory Syncytial Virus Infection in US Infants. J Infect Dis. 2019; (In press).
49. Tamaki R, Tallo VL, Tan AG, et al. Comprehensive Etiological and Epidemiological Study on Acute Respiratory Infections in Children: Providing Evidence for the Prevention and Control of Childhood Pneumonia in the Philippines. J Disaster Res. 2018; 13(4):740–750.
50. Philippine Statistics Authority. Population of Region VIII - Central Visayas (Based on the 2015 Census of Population). 2016; Available at: https://psa.gov.ph/content/population-region-viii-eastern-visayas-based-2015-census-population. Accessed on 12 Sep, 2019.
51. Schreiner M. A Simple Poverty Scorecard for the Philippines. Philipp. J. Dev. 2007 Available at:http://dirp4.pids.gov.ph/ris/pjd/pidspjd07-2poverty.pdf. Accessed on 12 Sep, 2019.
52. Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS. WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015. Vaccine. 2016; 34(2):190–197.
53. World Health Organization. Technical bases for the WHO recommendations on the management of pneumonia in children at first-level health facilities. 1991; Available at: https://www.who.int/maternal_child_adolescent/documents/ari_91_20/en/. Accessed on 12 Sep, 2019.
54. Suzuki A, Lupisan S, Furuse Y, et al. Respiratory viruses from hospitalized children with severe pneumonia in the Philippines. BMC Infect Dis [Internet]. BMC Infectious Diseases; 2012; 12(267).
55. Bellau-Pujol S, Vabret A, Legrand L, et al. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. J Virol Methods. 2005; 126:53–63.
56. Heim A, Ebnet C, Harste G, Pring-Åkerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol. 2003; 70(2):228–239.
57. National Institute for Infectious Diseases. National Institute for Infectious Diseases. Influenza Diagnosis Manual [Japanese]. 2014; Available at: https://www.niid.go.jp/niid/images/lab-manual/Influenza2014.pdf. Accessed on 12 Sep, 2019.
58. Malasao R, Okamoto M, Chaimongkol N, et al. Molecular characterization of human respiratory syncytial virus in the Philippines, 2012-2013. PLoS One. 2015; 10(11):e0142192.
59. Bonroy C, Vankeerberghen A, Boel A, Beenhouwer H De. Use of a multiplex real-time PCR to study the incidence of human metapneumovirus and human respiratory syncytial virus infections during two winter seasons in a Belgian paediatric hospital. Clin Microbiol Infect. 2007; 13(5):504– 509.
60. Matsuzaki Y, Takashita E, Okamoto M, et al. Evaluation of a new rapid antigen test using immunochromatography for detection of human metapneumovirus in comparison with real-time PCR assay. J Clin Microbiol. 2009; 47(9):2981–2984.
61. Sato M, Saito R, Sakai T, et al. Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons. J Clin Microbiol. 2005; 43(1):36–40.
62. Peret TCT, Hall CB, Schnabel KC, Golub JA, Anderson LJ. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol. 1998; 79(9):2221–2229.
63. World Health Organization. WHO Reference 2007 STATA macro package [Internet]. World Heal. Organ. 2007; Available at: https://www.who.int/growthref/tools/readme_stata.pdf?ua=1. Accessed on 15 Sep, 2019.
64. Havers FP, Fry AM, Goswami D, et al. Population-based Incidence of Childhood Pneumonia Associated With Viral Infections in Bangladesh. Pediatr Infect Dis J. 2019; 38(4):344–350.
65. Krishnan A, Kumar R, Broor S, et al. Epidemiology of viral acute lower respiratory infections in a community-based cohort of rural north Indian children. J Glob Health. 2019; 9(1):010433.
66. Sarna M, Ware RS, Sloots TP, Nissen MD, Grimwood K, Lambert SB. The burden of community- managed acute respiratory infections in the first 2-years of life. Pediatr Pulmonol. 2016; 51(12):1336–1346.
67. Ueno F, Tamaki R, Saito M, et al. Age‐specific incidence rates and risk factors for respiratory syncytial virus‐associated lower respiratory tract illness in cohort children under 5 years old in the Philippines. Influenza Other Respi Viruses. 2019; (September 2018).
68. Simões EAF, Mutyara K, Soh S, Agustian D, Hibberd ML, Kartasasmita CB. The epidemiology of respiratory syncytial virus lower respiratory tract infections in children less than 5 years of age in indonesia. Pediatr Infect Dis J. 2011; 30(9):778–784.
69. Boonyaratanakornkit J, Englund JA, Magaret AS, et al. Primary and Repeated Respiratory Viral Infections Among Infants in Rural Nepal. J Pediatric Infect Dis Soc. 2018; In press.
70. Papadopoulos NG, Moustaki M, Tsolia M, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002; 165(9):1285–1289.
71. Cilla G, Ate EO, Perez-Yarza EG, Montes M, Vicente D, Perez-Trallero E. Viruses in Community- Acquired Pneumonia in Children Aged Less Than 3 Years Old: High Rate of Viral Coinfection. J Med Virol. 2008; 80:1298–1304.
72. Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community- acquired pneumonia in adults. Thorax. 2008; 63(1):42–48.
73. Stensballe LG, Ravn H, Kristensen K, Meakins T, Aaby P, Simoes EAF. Seasonal Variation of Maternally Derived Respiratory Syncytial Virus Antibodies and Association with Infant Hospitalizations for Respiratory Syncytial Virus. J Pediatr. 2009; 154(2):296–299.
74. Chu HY, Steinhoff MC, Magaret A, et al. Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh. J Infect Dis. 2014; 210(10):1582– 1589.
75. Daleno C, Piralla A, Scala A, Senatore L, Principi N, Esposito S. Phylogenetic analysis of human rhinovirus isolates collected from otherwise healthy children with community-acquired pneumonia during five successive years. PLoS One. 2013; 8(11): e80614.
76. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000; 342(4):232–239.
77. Thompson MG, Levine MZ, Bino S, et al. Underdetection of laboratory-confirmed influenza- associated hospital admissions among infants: a multicentre, prospective study. Lancet Child Adolesc Heal. 2019; 3(11):781–794.
78. Yamamoto D, Okamoto M, Lupisan S, et al. Impact of human adenovirus serotype 7 in hospitalized children with severe fatal pneumonia in the Philippines. Jpn J Infect Dis. 2014; 67(2):105–110.
79. Imamura T, Fuji N, Suzuki A, et al. Enterovirus 68 among children with severe acute respiratory infection, the Philippines. Emerg Infect Dis. 2011; 17(8):1430–1435.
80. Marguet C, Lubrano M, Gueudin M, et al. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS One. 2009; 4(2):e4596.
81. Cho HJ, Shim SY, Son DW, Sun YH, Tchah H, Jeon IS. Respiratory viruses in neonates hospitalized with acute lower respiratory tract infections. Pediatr Int. 2013; 55(1):49–53.
82. Farzin A, Saha SK, Baqui AH, et al. Population-based incidence and etiology of community-acquired neonatal viral infections in Bangladesh: A community-based and hospital-based surveillance study. Pediatr Infect Dis J. 2015; 34(7):706–711.
83. Sarna M, Alsaleh A, Lambert SB, et al. Respiratory viruses in neonates: A prospective, community- based birth cohort study. Pediatr Infect Dis J. 2016; 35(12):1355–1357.
84. Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal Ed. 2005; 103:211–219.
85. Regamey N, Kaiser L, Roiha HL, et al. Viral etiology of acute respiratory infections with cough in infancy: A community-based birth cohort study. Pediatr Infect Dis J. 2008; 27(2):100–105.
86. Anders KL, Nguyen HL, Nguyen NM, et al. Epidemiology and virology of acute respiratory infections during the first year of life: A birth cohort study in Vietnam. Pediatr Infect Dis J. 2015; 34(4):361–370.
87. Kosai H, Tamaki R, Saito M, et al. Incidence and risk factors of childhood pneumonia-like episodes in Biliran Island, Philippines - A community-based study. PLoS One. 2015; 10(5):e0125009.
88. Vanker A, Barnett W, Workman L, et al. Early-life exposure to indoor air pollution or tobacco smoke and lower respiratory tract illness and wheezing in African infants: a longitudinal birth cohort study. Lancet Planet Heal. 2017; 1(8):e328–e336.
89. Gibbs K, Collaco JM, McGrath-Morrow SA. Impact of tobacco smoke and nicotine exposure on lung development. Chest. 2016; 149(2):552–561.
90. Arifeen SE, Black RE, Caulfield LE, et al. Infant growth patterns in the slums of Dhaka in relation to birth weight, intrauterine growth retardation, and prematurity. Am J Clin Nutr. 2000; 72:1010–1017.
91. Adair LS. Low birth weight and intrauterine growth retardation in Filipino infants. Pediatrics. 1989; 84(4):613–22.
92. Barsam FJBG, Borges GSD, Severino ABA, Mello LM De, Silva AS Da, Nunes AA. Factors associated with community-acquired pneumonia in hospitalised children and adolescents aged 6 months to 13 years old. Eur J Pediatr. 2013; 172(4):493–499.
93. César JA, Victora CG, Barros FC, Santos IS, Flores JA. Impact of breast feeding on admission for pneumonia during postneonatal period in Brazil: Nested case-control study. Br Med J. 1999; 318(7194):1316–1320.
94. Okiro EA, Ngama M, Bett A, Cane PA, Medley GF, James Nokes D. Factors associated with increased risk of progression to respiratory syncytial virus-associated pneumonia in young Kenyan children. Trop Med Int Heal. 2008; 13(7):914–926.
95. Trefny P, Stricker T, Baerlocher C, Sennhauser FH. Family history of atopy and clinical course of RSV infection in ambulatory and hospitalized infants. Pediatr Pulmonol. 2000; 30(4):302–306.
96. Stensballe LG, Kristensen K, Simoes EAF, et al. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: A nested case-control study. Pediatrics. 2006; 118(5).
97. Philippine Academy of Pediatric Pulmonologists. CHILDHOOD ASTHMA. 1995.
98. Paynter S, Ware RS, Lucero MG, et al. Malnutrition: a risk factor for severe respiratory syncytial virus infection and hospitalization. Pediatr Infect Dis J. 2014; 33(3):267–271.
99. Restori KH, Srinivasa BT, Ward BJ, Fixman ED. Neonatal immunity, respiratory virus infections, and the development of asthmastori, Katherine H. Srinivasa, Bh. Front Immunol. 2018; 9(JUN):1– 18.
100. Kiang D, Kalra I, Yagi S, et al. Assay for 5' noncoding region analysis of all human rhinovirus prototype strains. J Clin Microbiol. 2008; 46(11):3736–3745.
101. Kiang D, Yagi S, Kantardjieff KA, Kim EJ, Louie JK, Schnurr DP. Molecular characterization of a variant rhinovirus from an outbreak associated with uncommonly high mortality. J Clin Virol. 2007; 38(3):227–237.
論文の公開元へ
